Company Filing History:
Years Active: 2004-2015
Title: **Isabelle M. Maisonneuve: Innovator in Obesity and Addiction Treatment**
Introduction
Isabelle M. Maisonneuve, based in Delmar, NY, is an accomplished inventor recognized for her significant contributions to the fields of obesity treatment and addiction disorders. With two patents to her name, she is driving innovation in pharmacological approaches that aim to improve health outcomes for various patient populations.
Latest Patents
Among her notable inventions, Maisonneuve has developed an innovative method for treating obesity by utilizing ibogamine congeners. This patent details a complex compound formula that represents a novel approach to managing obesity through pharmaceutical intervention. Additionally, her work encompasses methods and compositions targeted at treating addiction disorders, utilizing a strategic combination of alpha and beta nicotinic receptor antagonists. This innovative method highlights her commitment to advancing medical treatments for substance dependencies, enhancing therapeutic options available to healthcare providers.
Career Highlights
Isabelle is affiliated with Albany Medical College, where she leverages her expertise in research and innovation. Her work is instrumental in exploring new solutions that could ultimately improve the quality of life for patients struggling with obesity and addiction.
Collaborations
Throughout her career, Maisonneuve has collaborated with esteemed colleagues such as Stanley D. Glick and Olga D. Taraschenko. Together, they contribute to research initiatives that deepen our understanding of addiction and obesity, paving the way for future advancements in treatment methodologies.
Conclusion
Isabelle M. Maisonneuve is a leading figure in the innovation of therapeutic solutions for obesity and addiction disorders. Her patents reflect a blend of scientific knowledge and practical application, underlining her importance in the medical research community. Through her work at Albany Medical College and collaborations with fellow researchers, she continues to influence the landscape of healthcare innovation significantly.